ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development and Validation of a Novel Prognostic Model for Lower-Grade Glioma Based on Enhancer RNA-Regulated Prognostic Genes

Tian, Wei; Yan, Guangcan; Chen, Kegong; Han, Xinhao; Zhang, Wei; Sun, Lin; Zhang, Qi; Zhang, Yafeng; Li, Yan; Liu, Meina*; Zhang, Qiuju*哈尔滨医科大学
Frontiers in Oncology2022-3-1DOI: 10.3389/fonc.2022.714338
4被引11阅读
引用收藏
分享

摘要

Enhancer RNAs (eRNAs) are present specifically in tumors, where they affect the expression of eRNA-regulated genes (ERGs). Owing to this characteristic, ERGs were hypothesized to improve prognosis of overall survival in heterogeneous low-grade and intermediate-grade gliomas. This study aimed to construct and validate an ERG prognostic tool to facilitate clinical management, and offer more effective diagnostic and therapeutic biomarkers for glioma. Survival-related eRNAs were identified, and their ERGs were selected based on eRNA and target gene information. The ERG prognostic model was constructed and validated using internal and external validation cohorts. Finally, biological differences related to the ERG signature were analysed to explore the potential mechanisms influencing survival outcomes. Thirteen ERGs were identified and used to build an ERG risk signature, which included five super-enhancer RNA (seRNA)-regulated genes and five LGG-specific eRNA-regulated genes. The prognostic nomogram established based on combining the ERG score, age, and sex was evaluated by calibration curves, clinical utility, Harrell's concordance index (0.86; 95% CI: 0.83-0.90), and time-dependent receiver operator characteristic curves. We also explored potential immune-related mechanisms that might cause variation in survival. The established prognostic model displayed high validity and robustness. Several immune-related genes regulated by seRNAs or specific eRNAs were identified, indicating that these transcripts or their genes were potential targets for improving immunotherapeutic/therapeutic outcomes. The functions of an important specific eRNA-regulated gene (USP28) were validated in robust vitro experiments. In addition, the ERG risk signature was significantly associated with the immune microenvironment and other immune-related features.

学科与关键词

关键词
enhancer RNAsuper-enhancer RNAgliomaprognosisnomogram
相关
加载中…
  • A Novel Prognostic Tool for Glioma Based on Enhancer RNA-Regulated Immune Genes
    Tian, Wei; Chen, Kegong; Yan, Guangcan; Han, Xinhao; Liu, Yanlong; Zhang, Qiuju*; Liu, Meina*Frontiers in Cell and Developmental Biology, 2022, 9: 798445.被引 7
  • An integrated analysis of enhancer RNAs in glioma and a validation of their prognostic values
    Lin, Han; Yang, Yong; Hou, Chongxian; Zheng, Jiantao; Lv, Guangzhao; Mao, Rui; Xu, Peihong; Chen, Shanwei; Zhou, Yujun; Wang, Peng*; Zhou, Dong*American Journal of Translational Research, 2021, 13(8): 8611-8631.被引 8
  • The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma
    Hu, Yungang; Yang, Qingqing; Cai, Shuzhou; Wang, Wei; Fu, Shiyin*Frontiers in Genetics, 2023, 14: 1085584.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-03-01
卷期
第 12 卷
页码
714338
DOI
10.3389/fonc.2022.714338
期刊等级
3区
成果收录
SCIE

作者

  • T

    Tian, Wei (第一作者)

    harbin med univ

  • Y

    Yan, Guangcan

    harbin med univ

查看全部 11 位作者收起作者
  • C

    Chen, Kegong

    2 · harbin med univ

  • H

    Han, Xinhao

    harbin med univ

  • Z

    Zhang, Wei

    harbin med univ

  • S

    Sun, Lin

    harbin med univ

  • Z

    Zhang, Qi

  • Z

    Zhang, Yafeng

    harbin med univ

  • L

    Li, Yan

    harbin med univ

  • L

    Liu, Meina (通讯)

    harbin med univ

  • Z

    Zhang, Qiuju (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417